Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese Find New Treatment For Parkinson's Disease

This article was originally published in PharmAsia News

Executive Summary

Japanese researchers reported early success with genetically engineering a virus to produce dopamine in the brain, restoring motor function in five of six Parkinson's disease patients so far. The research was carried out at Jichi Medical University, which notes Japan has 120,000 Parkinson's patients. The viral gene used has an enzyme that produces dopamine and the researchers see it as a replacement for the current treatment of giving patients L-dopa, a dopamine precursor that becomes less effective as the disease progresses. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel